Stay updated on Setmelanotide in BBS and AS for Obesity Clinical Trial
Sign up to get notified when there's something new on the Setmelanotide in BBS and AS for Obesity Clinical Trial page.

Latest updates to the Setmelanotide in BBS and AS for Obesity Clinical Trial page
- Check3 days agoChange DetectedThere are no additions or deletions to report for this page.SummaryDifference0.2%

- Check10 days agoChange DetectedThe page now displays a new revision tag v3.6.4, replacing the previous v3.6.3, indicating a small update to the page content.SummaryDifference0.3%

- Check17 days agoChange DetectedNo textual changes were supplied for this page. The study record remains as previously published.SummaryDifference0.2%

- Check24 days agoChange DetectedThe Study Results section has been populated with phase 3 trial results for setmelanotide in Bardet-Biedl and Alström syndromes, including primary and secondary outcomes and hunger data. The page now reflects the completion status and availability of published results, providing context on efficacy and appetite effects over the treatment period.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a small technical update to the page version. No substantive content changes are indicated by this revision.SummaryDifference0.3%

- Check39 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2, indicating a minor administrative update to the page. It does not reflect changes to study details or participant-related information.SummaryDifference0.3%

Stay in the know with updates to Setmelanotide in BBS and AS for Obesity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Setmelanotide in BBS and AS for Obesity Clinical Trial page.